Pharma future & health

Business

Deal & Finance

Life Science M&A

Mergers and acquisitions in the pharmaceutical sector showed an upswing in 2023; Deloitte's experts predict that the favourable winds will continue in the current year, extending also to the MedTech sector.

Roche takes aim at inflammatory bowel disease

Sanofi’s strategic turnaround

Goodbye NASH, it’s Alfasigma’s time

Agreement for antiviral biologics low cost production

Baxter and Hillrom: advancing healthcare together

BIODRUGS & ATMP

BioDrugs & ATMP

62° AFI Symposium – Maria Luisa Nolli’s interview

The 62° AFI National Symposium opens with an initial session devoted to the evolution of advanced therapies for safer, more effective and accessible drugs for patients.

ONE HEALTH

ONE HEALTH

Rare Disease Day: the international event to increase knowledge and raise awareness

Redazione -
For seventeen years, World Rare Disease Day has been celebrated on February 29th (28th in leap years): the event, now of international scope, is...

DARWIN EU: towards easy and secure access to health data

Novel foods that divide

Seguici sui social

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe
spot_img
spot_img
spot_img
spot_img
spot_img
spot_img
© Newspaper WordPress Theme by TagDiv